The information highlighted (if any) are the most recent updates for this brand.
Nustendi is contraindicated in patients with a known hypersensitivity to ezetimibe tablets [see Post-marketing Experience under Adverse Reactions]. Hypersensitivity reactions including anaphylaxis, angioedema, rash and urticaria have been reported with ezetimibe.